» Articles » PMID: 22072062

ER Stress Sensitizes Cells to TRAIL Through Down-regulation of FLIP and Mcl-1 and PERK-dependent Up-regulation of TRAIL-R2

Overview
Journal Apoptosis
Publisher Springer
Date 2011 Nov 11
PMID 22072062
Citations 38
Authors
Affiliations
Soon will be listed here.
Abstract

Despite recent evidences suggesting that agents inducing endoplasmic reticulum (ER) stress could be exploited as potential antitumor drugs in combination with tumor necrosis factor-related apoptosis-inducing ligand (TRAIL), the mechanisms of this anticancer action are not fully understood. Moreover, the effects of ER stress and TRAIL in nontransformed cells remain to be investigated. In this study we report that ER stress-inducing agents sensitizes both transformed and nontransformed cells to TRAIL-induced apoptosis. In addition, glucose-regulated protein of 78 kDa (GRP78) knockdown by RNA interference induces ER stress and facilitates apoptosis by TRAIL. We demonstrate that TRAIL death-inducing signaling complex (DISC) formation and early signaling are enhanced in ER stressed cells. ER stress alters the cellular levels of different apoptosis-related proteins including a decline in the levels of FLIP and Mcl-1 and the up-regulation of TRAIL-R2. Up-regulation of TRAIL-R2 following ER stress is dependent on the expression of PKR-like ER kinase (PERK) and independent of CAAT/enhancer binding protein homologous protein (CHOP) and Ire1α. Silencing of TRAIL-R2 expression by siRNA blocks the ER stress-mediated sensitization to TRAIL-induced apoptosis. Furthermore, simultaneous silencing of cFLIP and Mcl-1 expression by RNA interference results in a marked sensitization to TRAIL-induced apoptosis. Finally, in FLIP-overexpressing cells ER stress-induced sensitization to TRAIL-activated apoptosis is markedly reduced. In summary, our data reveal a pleiotropic mechanism involving both apoptotic and anti-apoptotic proteins for the sensitizing effect of ER stress on the regulation of TRAIL receptor-mediated apoptosis in both transformed and nontransformed cells.

Citing Articles

IRE1 RNase controls CD95-mediated cell death.

Pelizzari-Raymundo D, Maltret V, Nivet M, Pineau R, Papaioannou A, Zhou X EMBO Rep. 2024; 25(4):1792-1813.

PMID: 38383861 PMC: 11014915. DOI: 10.1038/s44319-024-00095-9.


Involvement of Bid in the crosstalk between ferroptotic agent-induced ER stress and TRAIL-induced apoptosis.

Kim J, Najy A, Li J, Luo X, Kim H, Choudry M J Cell Physiol. 2022; 237(11):4180-4196.

PMID: 35994698 PMC: 9691566. DOI: 10.1002/jcp.30863.


BAY-885, a mitogen-activated protein kinase kinase 5 inhibitor, induces apoptosis by regulating the endoplasmic reticulum stress/Mcl-1/Bim pathway in breast cancer cells.

Wang L, Ji X, Mao C, Yu R Bioengineered. 2022; 13(5):12888-12898.

PMID: 35609325 PMC: 9275924. DOI: 10.1080/21655979.2022.2078557.


cFLIP downregulation is an early event required for endoplasmic reticulum stress-induced apoptosis in tumor cells.

Mora-Molina R, Stohr D, Rehm M, Lopez-Rivas A Cell Death Dis. 2022; 13(2):111.

PMID: 35115486 PMC: 8813907. DOI: 10.1038/s41419-022-04574-6.


ER stress-induced cell death proceeds independently of the TRAIL-R2 signaling axis in pancreatic β cells.

Hagenlocher C, Siebert R, Taschke B, Wieske S, Hausser A, Rehm M Cell Death Discov. 2022; 8(1):34.

PMID: 35075141 PMC: 8786928. DOI: 10.1038/s41420-022-00830-y.


References
1.
Frew A, Lindemann R, Martin B, Clarke C, Sharkey J, Anthony D . Combination therapy of established cancer using a histone deacetylase inhibitor and a TRAIL receptor agonist. Proc Natl Acad Sci U S A. 2008; 105(32):11317-22. PMC: 2516269. DOI: 10.1073/pnas.0801868105. View

2.
Krueger A, Schmitz I, Baumann S, Krammer P, Kirchhoff S . Cellular FLICE-inhibitory protein splice variants inhibit different steps of caspase-8 activation at the CD95 death-inducing signaling complex. J Biol Chem. 2001; 276(23):20633-40. DOI: 10.1074/jbc.M101780200. View

3.
Wang S, El-Deiry W . TRAIL and apoptosis induction by TNF-family death receptors. Oncogene. 2003; 22(53):8628-33. DOI: 10.1038/sj.onc.1207232. View

4.
Burikhanov R, Zhao Y, Goswami A, Qiu S, Schwarze S, Rangnekar V . The tumor suppressor Par-4 activates an extrinsic pathway for apoptosis. Cell. 2009; 138(2):377-88. PMC: 2774252. DOI: 10.1016/j.cell.2009.05.022. View

5.
Walczak H, Miller R, Ariail K, Gliniak B, Griffith T, Kubin M . Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo. Nat Med. 1999; 5(2):157-63. DOI: 10.1038/5517. View